Brigham and Womens selects Care Management

Care Management International, a medical management and clinical services smart sourcing provider, will administer the enrollment phase of a Member Outreach clinical trial at Brigham and Women’s Hospital (BWH) in Boston.

According to the Hoboken, N.J.-based company, the trial, funded by the National Institutes of Health, will assess whether education from clinical coaches improves adherence to osteoporosis medication in elderly members who are covered by the Pharmaceutical Assistance Contract for the Elderly program, a state-run prescription program for Pennsylvania residents with limited incomes.

Care Management said it will provide BWH with enrollment services and operational metrics on call summary statistics while gathering demographic data typically not available in the enrollment phase of these projects.

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.